Opportunities for improving the efficiency of paediatric HIV treatment programmes.

Samankaltaisia teoksia

• Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy.
  Tekijä: Crook, A, et al.
  Julkaistu: (2016)
• A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa.
  Tekijä: Bwakura-Dangarembizi, M, et al.
  Julkaistu: (2014)
• Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial.
  Tekijä: Kekitiinwa, A, et al.
  Julkaistu: (2013)
• Pubertal development in HIV-infected African children on first-line antiretroviral therapy.
  Tekijä: Szubert, A, et al.
  Julkaistu: (2015)
• Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapy.
  Tekijä: Bwakura-Dangarembizi, M, et al.
  Julkaistu: (2015)